Andersons pediatric cardiology 2366
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (97.15 KB, 3 trang )
causesof,1174t
clinicalfeaturesof,1173
definitionof,1173
differentialdiagnosisof,1178
echocardiographyin,1174–1175,1176f
electrocardiographyin,1174,1175f
endomyocardialbiopsyin,1175–1176,1177f
etiologyof,1173
hypersensitivity,drugsproducing,1111,1111b
infectious,1173
investigationsfor,1174–1176
inKawasakisyndrome,980,982
laboratoryfindingsin,1173–1174,1174b
otherimagingtechniquesfor,1175
prognosisof,1177–1178
radiologyin,1174
systemiclupuserythematosusand,1178
toxic,drugsproducing,1111,1111b
treatmentof,1176–1177
viral,1173
Myocardium,945
developmentof,59–82,Myocardialdevelopment
fetal,biophysicalpropertiesof,84–85
immature,performanceandphysiologyof,192
mediastinal,35f,39–40
primary,embryologyof,35–36,35f
secondary,35–36,35f
vascularizationof,embryologyof,46–47
Myocyte,regulationofmyocardialperformanceand,191
Myopathies,mitochondrial,cardiacinvolvementin,1097
Myosin,incardiomyocyte,71–72
β-myosin,fetaldevelopmentand,85
Myotonicmusculardystrophy,cardiacinvolvementin,1103–1104
Myxomas,cardiac,972–973,972f–973f
N
N6-methyladenosine(m6A),67
Naproxen,forcarditis,1017t
Narcotics,forcomplexcongenitalcardiacdisease,1400
Nasogastrictubefeeding,1500
NationalAnesthesiaClinicalOutcomesRegistry,1511t–1514t
NationalCongenitalHeartDiseaseAudit,1511t–1514t
NationalPediatricCardiologyQualityImprovementCollaborative,1507–1509,
1508f,1511t–1514t,1516
NationalRegisterforCongenitalHeartDefects,1511t–1514t
Natriureticpeptidesystem,inretentionofsodiumandwater,1198
NDD,Neurodevelopmentaldelay
Near-infraredspectroscopy(NIRS)
foracutecirculatoryfailure,1181
inFontanpathway,1275,1288
ofcentralnervoussystem,1290–1291,1291t
Near-term,definitionof,190b
Necrotizingarteritis,980
Necrotizingenterocolitis
nutritionand,1496
inprematurity,211
Nemalinemyopathy,cardiacinvolvementin,1105
Neo-aorticrootandvalve,arterialswitchproceduresand,693–694,694f
Neonatalinfectiveendocarditis,1059
Neonatalmortality
accordingtobirth,190t
rate,definitionof,190b
Neonatalstabilization,inFontanpathway,1273–1296
Neonates
bloodstreamsepsisin,1528
bradycardiain,336
criticalheartdiseasesin,1523,1523t
LQTSin,353
psychologicalstressofcardiacdiseasein,1455
supraventriculartachycardiain,345
Neoplasticdisease,pericarditisand,1069–1070
Nephroblastoma,renalhypertensionand,1135
Neprilysininhibitors,forchronicheartfailure,1201
Nesiritide,foracutecirculatoryfailure,1184t
Nestedcase-controlstudies,417
Networks,foruniventricularheart,1349–1350
Neuralcontrol,ofcirculation,1358–1359
Neurodevelopmentalcare,inFontanpathway,1291,1292t
Neurodevelopmentaldelay(NDD),1475
incardiactransplantation,1475–1476
incongenitalheartdisease,167
Neurodevelopmentaloutcomes,transpositionofthegreatarteriesand,692–693
Neurodevelopmentalscreening,1543–1544,1544b,1545f
Neurofibromatosis,renovascularhypertensionand,1134
Neurologiccare,forprematurity,211
Neurologicinjury,geneticsusceptibilityto,1397
Neurologicaldisorders,hypertensionand,1138
Newborn,atrialflutterin,347,348f
Niemann-Pickdisease,cardiacinvolvementin,1093
Nifedipineforhypertension,1140t–1141t
